11 -fluoro 15 -hydroxy PGF2 analogs as FP receptor antagonists

The FP prostaglandin receptor belongs to a family of prostaglandin receptors, all of which have seven-transmembrane domains and couple to specific G-proteins. When activated by the binding of a specific ligand (a prostaglandin belonging to one of several defined classes of prostaglandins) the G-prot...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Sharif, Najam A, Griffin, Brenda W
Format: Patent
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Sharif, Najam A
Griffin, Brenda W
description The FP prostaglandin receptor belongs to a family of prostaglandin receptors, all of which have seven-transmembrane domains and couple to specific G-proteins. When activated by the binding of a specific ligand (a prostaglandin belonging to one of several defined classes of prostaglandins) the G-proteins transmit and amplify within the cell a signal to their preferred prostaglandin receptors on the surface of the cell membrane. (Coleman et al., 46:205-229 (94)). Ligand-induced activation of the FP prostaglandin receptor is believed to involve activation of the enzyme phospholipase C (mediated by specific G-proteins), resulting in rapid hydrolysis of phosphatidylinositol 4,5-bisphosphate in the cell membrane. The products of this hydrolysis are inositol 1,4,5-trisphosphate (IP ) and diacylglycerol (DAG), which act as second messengers inside the cell. (Coleman et al., 46:205-229 (1994); Berridge, 361:315-325 (1993); Davis et al., 4,5- (USA) 84:3728-3732 (1987); Nakao et al., 3 3 155:257-264 (1993); and Griffin et al., 3 3 281: 845-854 (1997)). IP mobilizes Ca++ from intracellular stores and DAG activates protein kinase C. Together these second messengers activate various enzymes and other proteins to produce the final biological responses. The latter may involve tissue contraction, hormone release, fluid secretion, or initiation of an inflammatory response. Methods and compositions for the antagonism of FP receptor-mediated biological responses are disclosed.
format Patent
fullrecord <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_06649655</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>06649655</sourcerecordid><originalsourceid>FETCH-uspatents_grants_066496553</originalsourceid><addsrcrecordid>eNrjZLAzNFTQTcspzS_KVzA0VdDNqEwpyq-oVAhwdzNSSMxLzMlPL1ZILFZwC1AoSk1OLSjJLwIKlySm5-dlFpcU8zCwpiXmFKfyQmluBgU31xBnD93S4oLEktS8kuL49KJEEGVgZmZiaWZqakyEEgANry-C</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>11 -fluoro 15 -hydroxy PGF2 analogs as FP receptor antagonists</title><source>USPTO Issued Patents</source><creator>Sharif, Najam A ; Griffin, Brenda W</creator><creatorcontrib>Sharif, Najam A ; Griffin, Brenda W ; Alcon Manufacturing, Ltd</creatorcontrib><description>The FP prostaglandin receptor belongs to a family of prostaglandin receptors, all of which have seven-transmembrane domains and couple to specific G-proteins. When activated by the binding of a specific ligand (a prostaglandin belonging to one of several defined classes of prostaglandins) the G-proteins transmit and amplify within the cell a signal to their preferred prostaglandin receptors on the surface of the cell membrane. (Coleman et al., 46:205-229 (94)). Ligand-induced activation of the FP prostaglandin receptor is believed to involve activation of the enzyme phospholipase C (mediated by specific G-proteins), resulting in rapid hydrolysis of phosphatidylinositol 4,5-bisphosphate in the cell membrane. The products of this hydrolysis are inositol 1,4,5-trisphosphate (IP ) and diacylglycerol (DAG), which act as second messengers inside the cell. (Coleman et al., 46:205-229 (1994); Berridge, 361:315-325 (1993); Davis et al., 4,5- (USA) 84:3728-3732 (1987); Nakao et al., 3 3 155:257-264 (1993); and Griffin et al., 3 3 281: 845-854 (1997)). IP mobilizes Ca++ from intracellular stores and DAG activates protein kinase C. Together these second messengers activate various enzymes and other proteins to produce the final biological responses. The latter may involve tissue contraction, hormone release, fluid secretion, or initiation of an inflammatory response. Methods and compositions for the antagonism of FP receptor-mediated biological responses are disclosed.</description><language>eng</language><creationdate>2003</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/6649655$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,780,802,885,64039</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/6649655$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Sharif, Najam A</creatorcontrib><creatorcontrib>Griffin, Brenda W</creatorcontrib><creatorcontrib>Alcon Manufacturing, Ltd</creatorcontrib><title>11 -fluoro 15 -hydroxy PGF2 analogs as FP receptor antagonists</title><description>The FP prostaglandin receptor belongs to a family of prostaglandin receptors, all of which have seven-transmembrane domains and couple to specific G-proteins. When activated by the binding of a specific ligand (a prostaglandin belonging to one of several defined classes of prostaglandins) the G-proteins transmit and amplify within the cell a signal to their preferred prostaglandin receptors on the surface of the cell membrane. (Coleman et al., 46:205-229 (94)). Ligand-induced activation of the FP prostaglandin receptor is believed to involve activation of the enzyme phospholipase C (mediated by specific G-proteins), resulting in rapid hydrolysis of phosphatidylinositol 4,5-bisphosphate in the cell membrane. The products of this hydrolysis are inositol 1,4,5-trisphosphate (IP ) and diacylglycerol (DAG), which act as second messengers inside the cell. (Coleman et al., 46:205-229 (1994); Berridge, 361:315-325 (1993); Davis et al., 4,5- (USA) 84:3728-3732 (1987); Nakao et al., 3 3 155:257-264 (1993); and Griffin et al., 3 3 281: 845-854 (1997)). IP mobilizes Ca++ from intracellular stores and DAG activates protein kinase C. Together these second messengers activate various enzymes and other proteins to produce the final biological responses. The latter may involve tissue contraction, hormone release, fluid secretion, or initiation of an inflammatory response. Methods and compositions for the antagonism of FP receptor-mediated biological responses are disclosed.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2003</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNrjZLAzNFTQTcspzS_KVzA0VdDNqEwpyq-oVAhwdzNSSMxLzMlPL1ZILFZwC1AoSk1OLSjJLwIKlySm5-dlFpcU8zCwpiXmFKfyQmluBgU31xBnD93S4oLEktS8kuL49KJEEGVgZmZiaWZqakyEEgANry-C</recordid><startdate>20031118</startdate><enddate>20031118</enddate><creator>Sharif, Najam A</creator><creator>Griffin, Brenda W</creator><scope>EFH</scope></search><sort><creationdate>20031118</creationdate><title>11 -fluoro 15 -hydroxy PGF2 analogs as FP receptor antagonists</title><author>Sharif, Najam A ; Griffin, Brenda W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_066496553</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2003</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Sharif, Najam A</creatorcontrib><creatorcontrib>Griffin, Brenda W</creatorcontrib><creatorcontrib>Alcon Manufacturing, Ltd</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Sharif, Najam A</au><au>Griffin, Brenda W</au><aucorp>Alcon Manufacturing, Ltd</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>11 -fluoro 15 -hydroxy PGF2 analogs as FP receptor antagonists</title><date>2003-11-18</date><risdate>2003</risdate><abstract>The FP prostaglandin receptor belongs to a family of prostaglandin receptors, all of which have seven-transmembrane domains and couple to specific G-proteins. When activated by the binding of a specific ligand (a prostaglandin belonging to one of several defined classes of prostaglandins) the G-proteins transmit and amplify within the cell a signal to their preferred prostaglandin receptors on the surface of the cell membrane. (Coleman et al., 46:205-229 (94)). Ligand-induced activation of the FP prostaglandin receptor is believed to involve activation of the enzyme phospholipase C (mediated by specific G-proteins), resulting in rapid hydrolysis of phosphatidylinositol 4,5-bisphosphate in the cell membrane. The products of this hydrolysis are inositol 1,4,5-trisphosphate (IP ) and diacylglycerol (DAG), which act as second messengers inside the cell. (Coleman et al., 46:205-229 (1994); Berridge, 361:315-325 (1993); Davis et al., 4,5- (USA) 84:3728-3732 (1987); Nakao et al., 3 3 155:257-264 (1993); and Griffin et al., 3 3 281: 845-854 (1997)). IP mobilizes Ca++ from intracellular stores and DAG activates protein kinase C. Together these second messengers activate various enzymes and other proteins to produce the final biological responses. The latter may involve tissue contraction, hormone release, fluid secretion, or initiation of an inflammatory response. Methods and compositions for the antagonism of FP receptor-mediated biological responses are disclosed.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_uspatents_grants_06649655
source USPTO Issued Patents
title 11 -fluoro 15 -hydroxy PGF2 analogs as FP receptor antagonists
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T09%3A19%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Sharif,%20Najam%20A&rft.aucorp=Alcon%20Manufacturing,%20Ltd&rft.date=2003-11-18&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E06649655%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true